Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling.
Human cancers often contain genetic alterations that disable G1/S checkpoint control and loss of this checkpoint is thought to critically contribute to cancer generation by permitting inappropriate proliferation and distorting fate-driven cell cycle exit. The identification of cell permeable small m...
Main Authors: | Simon R Stockwell, Georgina Platt, S Elaine Barrie, Georgia Zoumpoulidou, Robert H Te Poele, G Wynne Aherne, Stuart C Wilson, Peter Sheldrake, Edward McDonald, Mathilde Venet, Christelle Soudy, Frédéric Elustondo, Laurent Rigoreau, Julian Blagg, Paul Workman, Michelle D Garrett, Sibylle Mittnacht |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3257223?pdf=render |
Similar Items
-
Rheb Inhibits Protein Synthesis by Activating the PERK-eIF2α Signaling Cascade
by: Richa Tyagi, et al.
Published: (2015-02-01) -
PERK/EIF2AK3 integrates endoplasmic reticulum stress-induced apoptosis, oxidative stress and autophagy responses in immortalised retinal pigment epithelial cells
by: Neil Saptarshi, et al.
Published: (2022-08-01) -
Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response.
by: Elizabeth Richardson, et al.
Published: (2012-01-01) -
Avarol Induces Apoptosis in Pancreatic Ductal Adenocarcinoma Cells by Activating PERK–eIF2α–CHOP Signaling
by: Takushi Namba, et al.
Published: (2015-04-01) -
EIF2AK3 variants in Dutch patients with Alzheimer's disease
by: Wong, T, et al.
Published: (2018)